Home » Market News » DirectorsTalk Highlights » Advanced Oncotherapy Director purchased more shares in the company
Advanced Oncotherapy Plc

Advanced Oncotherapy Director purchased more shares in the company

Advanced Oncotherapy (LON:AVO), the developer of next-generation proton therapy systems for cancer treatment, told DirectorsTalk that yesterday Dr Enrico Vanni, Non-Executive Director of the Company purchased 40,000 ordinary shares of 25 pence in the Company at a price of 54.5 pence per Ordinary Share.

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.